GnRH receptor agonist

A GnRH receptor agonist changes pituitary signalling so reproductive hormone production can be reduced under medical supervision. It first binds to GnRH receptors and, when exposure is continuous, makes the pituitary less responsive to the signal. This action can be useful in selected gynaecological and endocrine treatment plans.

The brain normally releases GnRH in pulses. Those pulses tell the pituitary to release signals that stimulate the ovaries or testes. A receptor agonist copies the message but changes the pattern when given continuously, so the downstream signals fall. The result can be less ovarian activity, fewer hormone-driven symptoms, or slowed puberty, depending on the reason for treatment. This is a controlled medical effect rather than a general hormone boost.

Keep the product information and dosing calendar available, and attend reviews even when symptoms improve. Tell your clinician about new bleeding, pelvic discomfort, hot flushes, headaches, mood changes, vision symptoms, or reactions where the medicine was given. Discuss pregnancy plans, contraception, breastfeeding, bone health, and medicines that may affect your care. If a dose is missed, contact the treatment service for a tailored instruction.

Use emergency services for trouble breathing, throat or facial swelling, seizure, fainting, or sudden severe illness. Seek prompt clinical advice for intense or worsening pelvic pain, heavy unexpected bleeding, severe headache, visual change, or a treatment-site reaction that spreads. Keep the medicine name and timing of the last dose ready when you call.

Ask why receptor suppression is suitable for your condition, how response will be measured, and which changes should be expected early in treatment. Discuss the review schedule, symptom relief options, fertility and contraception considerations, handling of delayed doses, and how the clinician will plan the transition away from treatment.